These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13024536)

  • 1. [Case of lymphatic leukemia with unusual skin manifestations].
    BOKONJIC N
    Med Arh; 1952; 6(4):89-97. PubMed ID: 13024536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the application of CB-1348 in lymphatic leukemias].
    LAWKOWICZ W; BECALSKI J
    Pol Arch Med Wewn; 1959; 29(3):420-2. PubMed ID: 13667708
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta radiol; 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas.
    GELLHORN A; HYMAN GA; ULTMANN JE
    J Am Med Assoc; 1956 Sep; 162(3):178-83. PubMed ID: 13357311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
    HANSEN PB
    Acta radiol; 1957 Mar; 47(3):210-16. PubMed ID: 13424344
    [No Abstract]   [Full Text] [Related]  

  • 7. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.
    ALTMAN SJ; HAUT A; CARTWRIGHT GE; WINTROBE MM
    Cancer; 1956; 9(3):512-7. PubMed ID: 13330000
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
    THEOLOGIDES A; KENNEDY BJ
    Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Profuse cutaneous lymphosis; clearing with combined cortisone and chloraminophen].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():201-2. PubMed ID: 13837805
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
    RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC
    Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic efficacy of nitrogen mustard in a case of chronic lymphatic leukemia with diffuse cutaneous leukemia].
    GIANOTTI F; LEVI L
    G Ital Dermatol; 1951; 92(3):179-87. PubMed ID: 14860566
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of the effect of degranol.
    SANDOR L; CERNY V; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():179-82. PubMed ID: 14441442
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the effectiveness of radioactive phosphorus and chlorambucil in patients with chronic lymphocytic leukemia.
    SPRAGUE CC
    Cancer Chemother Rep; 1962 Feb; 16():235-40. PubMed ID: 13915911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia.
    GALTON DA; WILTSHAW E; SZUR L; DACIE JV
    Br J Haematol; 1961 Jan; 7():73-98. PubMed ID: 13703205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of leukemia with urethane and nitrogen mustards].
    CHILOV K; IVANOV S
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1951; 4-5():9-38. PubMed ID: 14937908
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hematologic neoplasms with nitrogen oxide mustards].
    HORLIN W; SCHMITT W
    Dtsch Med Wochenschr; 1957 Feb; 82(7):247-50. PubMed ID: 13427484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Eosinophilic leukemia].
    MORELLI A; MAUREA C
    Haematologica; 1953; 37(5):435-98. PubMed ID: 13095858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.